iBio, Inc.
IBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420720
No open-market purchases or sales by iBio, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding iBio, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 87 | 1 | 90 | +4 |
| Shares | 43.4M | 70.3K | 44.7M | +1.40M (+3.2%) |
| Value | $65.5M | $107.0K | $47.6M | −$17.8M (−27.3%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held iBio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 181,094 | $192.0K | 0.02% |
| Renaissance Technologies LLC | 151,717 | $161.0K | 0.00% |
| SG Americas Securities, LLC | 135,523 | $144.0K | 0.00% |
| MetLife Investment Management | 83,176 | $88.2K | 0.00% |
| Franklin Resources Inc | 70,300 | $75.0K | 0.00% |
| Metropolitan Life Insurance Co | 62,929 | $66.7K | 0.00% |
| AXS Investments LLC | 43,832 | $46.0K | 0.02% |
| Parallax Volatility Advisers, L.P. | 17,875 | $19.0K | 0.00% |
| S.E.E.D. Planning Group LLC | 17,080 | $18.0K | 0.01% |
| Two Sigma Securities, LLC | 16,343 | $17.0K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 14,825 | $16.0K | 0.00% |
| Apollon Wealth Management, LLC | 14,300 | $15.0K | 0.00% |
| Mackenzie Financial Corp | 12,665 | $13.0K | 0.00% |
| HRT Financial LP | 10,898 | $11.0K | 0.00% |
| Koshinski Asset Management, Inc. | 2,000 | $2.12K | 0.00% |
| Strategic Asset Management, LLC | 1,000 | $1.00K | 0.00% |
| Ellevest, Inc. | 187 | $0 | 0.00% |
Sold out (13)
Institutions that held iBio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Marshall Wace, LLP | 170,524 | $257.0K |
| Belpointe Asset Management LLC | 117,750 | $178.0K |
| Winton Group Ltd | 77,707 | $117.0K |
| Schonfeld Strategic Advisors LLC | 37,700 | $57.0K |
| Ergoteles LLC | 35,700 | $54.0K |
| UBS Group AG | 23,324 | $35.0K |
| Millennium Management LLC | 19,225 | $29.0K |
| Cubist Systematic Strategies, LLC | 16,522 | $25.0K |
| Triton Wealth Management, PLLC | 10,300 | $13.0K |
| Retirement Group, LLC | 7,135 | $11.0K |
| Spire Wealth Management | 1,200 | $2.00K |
| Advisory Services Network, LLC | 800 | $1.00K |
| Red Door Wealth Management, LLC | 325 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held iBio, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 70,300 | $107.0K |